Literature DB >> 28586104

Reply to: Estimating the Full Value of High-Dose Influenza Vaccine.

Jonathan M Raviotta1, Kenneth J Smith1, Jay DePasse2, Shawn T Brown2, Eunha Shim3, Mary Patricia Nowalk1, Richard K Zimmerman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28586104      PMCID： PMC5603375          DOI： 10.1111/jgs.14976

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  7 in total

1.  The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Authors:  Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

2.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

3.  Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.

Authors:  Ayman Chit; Julie Roiz; Benjamin Briquet; David P Greenberg
Journal:  Vaccine       Date:  2014-11-11       Impact factor: 3.641

4.  Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults.

Authors:  Jonathan M Raviotta; Kenneth J Smith; Jay DePasse; Shawn T Brown; Eunha Shim; Mary Patricia Nowalk; Richard K Zimmerman
Journal:  J Am Geriatr Soc       Date:  2016-10-06       Impact factor: 5.562

5.  Cochrane re-arranged: support for policies to vaccinate elderly people against influenza.

Authors:  Walter E P Beyer; Janet McElhaney; Derek J Smith; Arnold S Monto; Jonathan S Nguyen-Van-Tam; Albert D M E Osterhaus
Journal:  Vaccine       Date:  2013-10-03       Impact factor: 3.641

6.  Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

Authors:  Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia
Journal:  J Infect Dis       Date:  2014-11-18       Impact factor: 5.226

7.  Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season.

Authors:  Carrie Reed; Inkyu Kevin Kim; James A Singleton; Sandra S Chaves; Brendan Flannery; Lyn Finelli; Alicia Fry; Erin Burns; Paul Gargiullo; Daniel Jernigan; Nancy Cox; Joseph Bresee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-12       Impact factor: 17.586
  7 in total
  1 in total

1.  Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis.

Authors:  Kenneth J Smith; Glenson France; Mary Patricia Nowalk; Jonathan M Raviotta; Jay DePasse; Angela Wateska; Eunha Shim; Richard K Zimmerman
Journal:  Am J Prev Med       Date:  2019-02-14       Impact factor: 5.043
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.